70+ Workers To Be Laid Off At Parsippany Pharmaceutical Company

PARSIPPANY, NJ — A privately owned, biopharma company based in Parsippany has planned to lay off a combined total of more than 70 positions in the area, according to documents filed with the state.

Ferring Pharmaceuticals, a leader in reproductive medicine and maternal health, uro-oncology and in specialty areas within orthopedics and gastroenterology, is preparing a round of layoffs in Parsippany.

In a filing with the New Jersey Division of Workforce and Development, the company announced that 79 employees would be terminated early into the new year.

Those layoffs will take effect on March 5, according to a WARN Notice shared by the New Jersey Department of Labor.

In addition, 55 employees at the company’s Roseville, Minnesota, hub will also be laid off by Feb. 5.

"Ferring Pharmaceuticals (US) has optimized resources to align with its revised business strategy. The roles that were eliminated include employees located around the country reporting to our Parsippany, NJ office. We anticipate that a number of these employees will be redeployed, which will result in a limited number of actual job reductions," a Ferring Pharmaceuticals spokesperson told Patch.

Employees were reportedly informed of the layoffs this past week, and some were given the opportunity to transition into new positions if it was feasible to do so, according to KSTP-TV.

Ferring's 25-acre facility at 100 Interpace Pkwy, in Parsippany, currently employs 500 workers across manufacturing, commercial, clinical development, management, and administration functions. "It’s where our people share ideas to ultimately develop, manufacture and market new therapies to help people build families, stay healthy and fight disease," the company said.

Worker Adjustment and Retraining Notification (WARN) notices normally cover mass layoffs or facility closings as part of the Worker Adjustment and Retraining Notification Act of 1989.